NATH BIOGENES (INDIA)
Back to Balance Sheet
|
NATH BIOGENES (INDIA) Last 5 Year Profit & Loss Account Balance History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2013 | Mar2012 | |
---|---|---|---|---|---|
Profit & Loss Account Balance | ₹441 Cr | ₹406 Cr | ₹374 Cr | ₹26 Cr | ₹14 Cr |
What is the latest Profit & Loss Account Balance ratio of NATH BIOGENES (INDIA) ?
Year | Profit & Loss Account Balance |
---|---|
Mar2024 | ₹441 Cr |
Mar2023 | ₹406 Cr |
Mar2022 | ₹374 Cr |
Mar2013 | ₹26 Cr |
Mar2012 | ₹14 Cr |
How is Profit & Loss Account Balance of NATH BIOGENES (INDIA) Trending?
Years | Profit & Loss Account Balance | % Change | |
---|---|---|---|
Mar2024 | ₹441 Cr | 8.83 | |
Mar2023 | ₹406 Cr | 8.34 | |
Mar2022 | ₹374 Cr | 1,347.92 | |
Mar2013 | ₹26 Cr | 83.22 | |
Mar2012 | ₹14 Cr | - |
Compare Profit & Loss Account Balance of peers of NATH BIOGENES (INDIA)
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
NATH BIOGENES (INDIA) | ₹302.1 Cr | -5.6% | 1.9% | -16.4% | Stock Analytics | |
BOMBAY BURMAH TRADING CORPORATION | ₹13,295.0 Cr | -0.8% | 6.7% | 26.7% | Stock Analytics | |
KAVERI SEED COMPANY | ₹7,349.6 Cr | -8.1% | 12.8% | 87.4% | Stock Analytics | |
VENKYS (INDIA) | ₹2,392.0 Cr | -1.6% | 1% | -2.2% | Stock Analytics | |
BOMBAY SUPER HYBRID SEEDS | ₹1,429.6 Cr | -12.8% | 8.2% | -36.7% | Stock Analytics | |
INDO US BIOTECH | ₹340.9 Cr | -1.9% | 8.4% | -29.5% | Stock Analytics |
NATH BIOGENES (INDIA) Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
NATH BIOGENES (INDIA) | -5.6% |
1.9% |
-16.4% |
SENSEX | 0.8% |
3.8% |
8.4% |
You may also like the below Video Courses